[Effect of a new vasotherapeutic agent 3,7-dimethyl-1-(oxo-hexyl)-xanthine on lipid metabolism: lipolysis in adipose tissue].
D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D004822:Epididymis; D004837:Epinephrine / Q000494:pharmacology; D005227:Fatty Acids / Q000032:analysis; D005990:Glycerol / Q000032:analysis; D066298:In Vitro Techniques; D007274:Injections, Intraperitoneal; D007659:Ketones; D050356:Lipid Metabolism; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D013268:Stimulation, Chemical; D013806:Theophylline / Q000008:administration & dosage / Q000494:pharmacology; D014970:Xanthines / Q000494:pharmacology*
D005227:Fatty Acids; D007659:Ketones; D014970:Xanthines; D013806:Theophylline; D005990:Glycerol; D004837:Epinephrine
Wirkung des Vasotherapeutikums 3,7-Dimethyl-1-(5-oxo-hexyl)-xanthin auf den Fettstoffwechsel: Lipolyse am Fettgewebe.